Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 29 December 2025 Vol. No. 14 ; Issue No.715
Publications

1. George GS, Patil A, Moirangthem R, Doibale PN, Manjrekar A, Golapkar SV, Panse N, Krishnatreya M, Mishra A, Singh A, Rumgay H, Hosseini B, Chaturvedi A, Rajaraman P, Olsson A, Soerjomataram I, Chaturvedi P, Dikshit R, Mhatre S (2025). Association of alcohol and different types of alcoholic beverages on the risk of buccal mucosa cancer in Indian men: a multicentre case-control study. BMJ Global Health. 10(12):e017392.

2. Chopra S, Samanta A, Nagar A, Mittal P, Gupta A, Mulani J, Jain J, Ghadi Y, Sawant P, Rath S, Ghosh J, Gupta S(2025). Is single implant and multiple fractions radio-biologically iso-effective for cervical cancer high-dose-rate brachytherapy: Observation from patient cohorts during COVID pandemic. Brachytherapy.

3. Saha A, Pan A, Ghosh D, Pal A, Guin S, Redhu AK, Gota V, Maiti D (2025). A general strategy to access pharmaceutically relevant pyridines from nitroarenes. Angewandte Chemie.

4. Le Guevelou J, Zilli T, Ferrario F, Murthy V, Tree A, Loblaw A, Van der Heide UA, Kishan A, Draulans C, Martin J, Ost P, Sargos P (2025). Reducing adverse effects in hypofractionated radiotherapy for prostate cancer: Clinical evidence and emerging mitigation strategies.Prostate Cancer and Prostatic Diseases.

5. Gupta R, Fielder T, Bal M..........Chernock R...Kamboj M...Patil A...Rane S...etal. on the behalf of the HN-CLEAR steering committee and clinical advisory group (2026). International consensus recommendations and alignment of terminology for the histopathological diagnosis of extranodal extension in head and neck squamous cell carcinoma: an HN-CLEAR initiative. Lancet Oncology. 27(1):e33-e44.

6. Meher RK, Maharana J, Kovvuri J, K. Nirmal Kumar, Pradhan T, Kailaje V, Ingle A, Sen S, Barkume M, Patkar M, Vaibhaw A, Mir SA, Ghosh A, Kamte S, Kamal A, Kode J (2025). A phenstatin-based indole-chalcone hybrid as novel anti-inflammatory agent targeting the NLRP3 Inflammasome: Leads from computational and preclinical studies. Bioorganic Chemistry.

Site of the Week

The Open Access Series of Imaging Studies (OASIS) is a project aimed at making neuroimaging data sets of the brain freely available to the scientific community.

desktop Image
Interesting Reads

Veillette A, Li J, Galindo CC, Davidson D, Tang Z (2025). Targeting phagocytosis checkpoints for cancer immunotherapy. Nature Reviews Cancer.

Video of the Week
Recognizing and Redefining the Unique Path of Invasive Lobular Carcinoma
Upcoming Events
Global Landscape of Cell and Gene Therapy by Dr.Siddhartha Mukherjee

December 30, 2025

At Khanolkar Auditorium, Khanolkar Shodhika, ACTREC, Kharghar, Navi Mumbai.

The First Khanolkar Oration by Dr. Ajit Kumar Mohanty, Chairman, AEC & Secretary, DAE, Government of India.

January 3, 2026

At Khanolkar Auditorium, Khanolkar Shodhika, ACTREC, Kharghar, Navi Mumbai.

Workshop on Fundamentals of Cervical Cancer Screening, Colposcopy & Pre-cancer Management

January 15-16, 2026

At ACTREC, Tata Memorial Centre, Kharghar.

Do You Know?

In 1996, FDA approved anastrozole (Arimidex) as a treatment for breast cancer. This drug blocks the production of estrogen.

back Image
Cancer News
Scientists develop targeted therapy for T-cell lymphomas and leukemias.

MedicalXpress, 25/12/2025

In the new study, the researchers used a phage-displayed antibody library, a powerful tool used to discover new antibodies, to create JX1.1, a new antibody that recognizes only the TRBC2 protein target and not the similar TRBC1 protein...

Study Warns: Even small amounts of alcohol increase oral cavity cancer risk.

Press Information Bureau, 24/12/2025

A landmark study by Centre for Cancer Epidemiology, The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) at the Tata Memorial Centre, Mumbai, has demonstrated that there is no safe limit for alcohol drinking in the development of oral cancer...

IIT Madras–Australia Team Develops Precision Nanoinjection System for Breast Cancer.

Health Dialogues,22/12/2025

The highlight of this research is its combination of high precision, thermal stability, and long-term drug release (up to 700 hours) — a feat that addresses common drawbacks of existing nanocarrier systems, such as burst release and poor compatibility...

2025 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)